Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
Complete Genome Sequences of Six .

Genome announcements

Fagerlund A, Langsrud S, Moen B, Heir E, Møretrø T.
PMID: 29449378
Genome Announc. 2018 Feb 15;6(7). doi: 10.1128/genomeA.00016-18.

No abstract available.

Cite
Fagerlund A, Langsrud S, Moen B, et al. Complete Genome Sequences of Six . Genome Announc. 2018;6(7)doi: 10.1128/genomeA.00016-18.
Fagerlund, A., Langsrud, S., Moen, B., Heir, E., & Møretrø, T. (2018). Complete Genome Sequences of Six . Genome announcements, 6(7), . https://doi.org/10.1128/genomeA.00016-18
Fagerlund, Annette, et al. "Complete Genome Sequences of Six ." Genome announcements vol. 6,7 (2018). doi: https://doi.org/10.1128/genomeA.00016-18
Fagerlund A, Langsrud S, Moen B, Heir E, Møretrø T. Complete Genome Sequences of Six . Genome Announc. 2018 Feb 15;6(7). doi: 10.1128/genomeA.00016-18. PMID: 29449378; PMCID: PMC5814496.
Copy Download .nbib Format: NLM
[Increase the number of MR examinations! Optimal utilization contributes to cost-effective health care].

Lakartidningen

Bergström K, Ericson K, Fagerlund M, Hindmarsh T, Holtås S.
PMID: 11370415
Lakartidningen. 2001 Apr 18;98(16):1952-3.

No abstract available.

Cite
Bergström K, Ericson K, Fagerlund M, et al. Oka antalet MR-undersökningar. Optimalt utnyttjande bidrar till kostnadseffektiv sjukvård. [Increase the number of MR examinations! Optimal utilization contributes to cost-effective health care]. Lakartidningen. 2001;98(16):1952-3
Bergström, K., Ericson, K., Fagerlund, M., Hindmarsh, T., & Holtås, S. (2001). Oka antalet MR-undersökningar. Optimalt utnyttjande bidrar till kostnadseffektiv sjukvård. [Increase the number of MR examinations! Optimal utilization contributes to cost-effective health care]. Lakartidningen, 98(16), 1952-3.
Bergström, K, et al. "Oka antalet MR-undersökningar. Optimalt utnyttjande bidrar till kostnadseffektiv sjukvård." [Increase the number of MR examinations! Optimal utilization contributes to cost-effective health care]. Lakartidningen vol. 98,16 (2001): 1952-3.
Bergström K, Ericson K, Fagerlund M, Hindmarsh T, Holtås S. Oka antalet MR-undersökningar. Optimalt utnyttjande bidrar till kostnadseffektiv sjukvård. [Increase the number of MR examinations! Optimal utilization contributes to cost-effective health care]. Lakartidningen. 2001 Apr 18;98(16):1952-3. Swedish. PMID: 11370415.
Copy Download .nbib Format: NLM
Two-phase derivatization of pentazocine with chloroformate esters and determination by gas chromatography.

Journal of pharmaceutical and biomedical analysis

Hartvig P, Fagerlund C, Bondesson U.
PMID: 16867731
J Pharm Biomed Anal. 1984;2(3):509-17. doi: 10.1016/0731-7085(84)80054-0.

Two-phase derivatization with chloroformate esters of tertiary amines that contain a phenol group has been studied. The derivatives were analysed by gas chromatography with sensitive and selective detectors. The N,O-bis derivative of pentazocine was formed using an aqueous phase...

Cite
Hartvig P, Fagerlund C, Bondesson U. Two-phase derivatization of pentazocine with chloroformate esters and determination by gas chromatography. J Pharm Biomed Anal. 1984;2(3):509-17doi: 10.1016/0731-7085(84)80054-0.
Hartvig, P., Fagerlund, C., & Bondesson, U. (1984). Two-phase derivatization of pentazocine with chloroformate esters and determination by gas chromatography. Journal of pharmaceutical and biomedical analysis, 2(3), 509-17. https://doi.org/10.1016/0731-7085(84)80054-0
Hartvig, P, et al. "Two-phase derivatization of pentazocine with chloroformate esters and determination by gas chromatography." Journal of pharmaceutical and biomedical analysis vol. 2,3 (1984): 509-17. doi: https://doi.org/10.1016/0731-7085(84)80054-0
Hartvig P, Fagerlund C, Bondesson U. Two-phase derivatization of pentazocine with chloroformate esters and determination by gas chromatography. J Pharm Biomed Anal. 1984;2(3):509-17. doi: 10.1016/0731-7085(84)80054-0. PMID: 16867731.
Copy Download .nbib Format: NLM
An international measure of awareness and beliefs about cancer: development and testing of the ABC.

BMJ open

Simon AE, Forbes LJ, Boniface D, Warburton F, Brain KE, Dessaix A, Donnelly M, Haynes K, Hvidberg L, Lagerlund M, Petermann L, Tishelman C, Vedsted P, Vigmostad MN, Wardle J, Ramirez AJ.
PMID: 23253874
BMJ Open. 2012 Dec 18;2(6). doi: 10.1136/bmjopen-2012-001758. Print 2012.

OBJECTIVES: To develop an internationally validated measure of cancer awareness and beliefs; the awareness and beliefs about cancer (ABC) measure.DESIGN AND SETTING: Items modified from existing measures were assessed by a working group in six countries (Australia, Canada, Denmark,...

Cite
Simon AE, Forbes LJ, Boniface D, et al. An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open. 2012;2(6)doi: 10.1136/bmjopen-2012-001758.
Simon, A. E., Forbes, L. J., Boniface, D., Warburton, F., Brain, K. E., Dessaix, A., Donnelly, M., Haynes, K., Hvidberg, L., Lagerlund, M., Petermann, L., Tishelman, C., Vedsted, P., Vigmostad, M. N., Wardle, J., Ramirez, A. J. (2012). An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ open, 2(6), . https://doi.org/10.1136/bmjopen-2012-001758
Simon, Alice E, et al. "An international measure of awareness and beliefs about cancer: development and testing of the ABC." BMJ open vol. 2,6 (2012). doi: https://doi.org/10.1136/bmjopen-2012-001758
Simon AE, Forbes LJ, Boniface D, Warburton F, Brain KE, Dessaix A, Donnelly M, Haynes K, Hvidberg L, Lagerlund M, Petermann L, Tishelman C, Vedsted P, Vigmostad MN, Wardle J, Ramirez AJ. An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open. 2012 Dec 18;2(6). doi: 10.1136/bmjopen-2012-001758. Print 2012. PMID: 23253874; PMCID: PMC3547316.
Copy Download .nbib Format: NLM
Novel perspectives on the transcytotic route in osteoclasts.

BoneKEy reports

Hirvonen MJ, Fagerlund K, Lakkakorpi P, Väänänen HK, Mulari MT.
PMID: 23951543
Bonekey Rep. 2013 Mar 13;2:306. doi: 10.1038/bonekey.2013.40. eCollection 2013.

We analyzed the characteristics of degraded bone matrix-delivering vesicles along the transcytotic route from the ruffled border to the functional secretory domain (FSD) in bone-penetrating osteoclasts. Cells of rat or human origin were cultured on bovine bone slices and...

Cite
Hirvonen MJ, Fagerlund K, Lakkakorpi P, et al. Novel perspectives on the transcytotic route in osteoclasts. Bonekey Rep. 2013;2:306doi: 10.1038/bonekey.2013.40.
Hirvonen, M. J., Fagerlund, K., Lakkakorpi, P., Väänänen, H. K., & Mulari, M. T. (2013). Novel perspectives on the transcytotic route in osteoclasts. BoneKEy reports, 2306. https://doi.org/10.1038/bonekey.2013.40
Hirvonen, Mirkka J, et al. "Novel perspectives on the transcytotic route in osteoclasts." BoneKEy reports vol. 2 (2013): 306. doi: https://doi.org/10.1038/bonekey.2013.40
Hirvonen MJ, Fagerlund K, Lakkakorpi P, Väänänen HK, Mulari MT. Novel perspectives on the transcytotic route in osteoclasts. Bonekey Rep. 2013 Mar 13;2:306. doi: 10.1038/bonekey.2013.40. eCollection 2013. PMID: 23951543; PMCID: PMC3722746.
Copy Download .nbib Format: NLM
Frequent sleep-related bitemporal focal seizures in transient epileptic amnesia syndrome: Evidence from ictal video-EEG.

Epilepsia open

Burkholder DB, Jones AL, Jones DT, Fabris RR, Britton JW, Lagerlund TD, So EL, Cascino GD, Worrell GA, Shin C, St Louis EK.
PMID: 29588954
Epilepsia Open. 2017 Feb 07;2(2):255-259. doi: 10.1002/epi4.12040. eCollection 2017 Jun.

Two patients who shared similar presenting clinical features of anterograde and retrograde autobiographical amnesia typical of transient epileptic amnesia (TEA) underwent prolonged video electroencephalogram (VEEG) monitoring and were found to have sleep-activated epileptiform activity and frequent subclinical bitemporal seizures...

Cite
Burkholder DB, Jones AL, Jones DT, et al. Frequent sleep-related bitemporal focal seizures in transient epileptic amnesia syndrome: Evidence from ictal video-EEG. Epilepsia Open. 2017;2(2):255-259doi: 10.1002/epi4.12040.
Burkholder, D. B., Jones, A. L., Jones, D. T., Fabris, R. R., Britton, J. W., Lagerlund, T. D., So, E. L., Cascino, G. D., Worrell, G. A., Shin, C., & St Louis, E. K. (2017). Frequent sleep-related bitemporal focal seizures in transient epileptic amnesia syndrome: Evidence from ictal video-EEG. Epilepsia open, 2(2), 255-259. https://doi.org/10.1002/epi4.12040
Burkholder, David B, et al. "Frequent sleep-related bitemporal focal seizures in transient epileptic amnesia syndrome: Evidence from ictal video-EEG." Epilepsia open vol. 2,2 (2017): 255-259. doi: https://doi.org/10.1002/epi4.12040
Burkholder DB, Jones AL, Jones DT, Fabris RR, Britton JW, Lagerlund TD, So EL, Cascino GD, Worrell GA, Shin C, St Louis EK. Frequent sleep-related bitemporal focal seizures in transient epileptic amnesia syndrome: Evidence from ictal video-EEG. Epilepsia Open. 2017 Feb 07;2(2):255-259. doi: 10.1002/epi4.12040. eCollection 2017 Jun. PMID: 29588954; PMCID: PMC5719851.
Copy Download .nbib Format: NLM
Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years.

Psychological medicine

Fagerlund B, Pantelis C, Jepsen JRM, Raghava JM, Rostrup E, Thomas MB, Nielsen MØ, Bojesen K, Jensen KG, Stentebjerg-Decara M, Klauber DG, Rudå D, Ebdrup BH, Jessen K, Sigvard A, Tangmose K, Jeppesen P, Correll CU, Fink-Jensen A, Pagsberg AK, Glenthøj BY.
PMID: 32156323
Psychol Med. 2021 Jul;51(9):1570-1580. doi: 10.1017/S0033291720000409. Epub 2020 Mar 11.

BACKGROUND: The typical onset of schizophrenia coincides with the maturational peak in cognition; however, for a significant proportion of patients the onset is before age 18 and after age 30 years. While cognitive deficits are considered core features of...

Cite
Fagerlund B, Pantelis C, Jepsen JRM, et al. Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years. Psychol Med. 2020;51(9):1570-1580doi: 10.1017/S0033291720000409.
Fagerlund, B., Pantelis, C., Jepsen, J. R. M., Raghava, J. M., Rostrup, E., Thomas, M. B., Nielsen, M. �. �., Bojesen, K., Jensen, K. G., Stentebjerg-Decara, M., Klauber, D. G., Rudå, D., Ebdrup, B. H., Jessen, K., Sigvard, A., Tangmose, K., Jeppesen, P., Correll, C. U., Fink-Jensen, A., Pagsberg, A. K., & Glenthøj, B. Y. (2021). Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years. Psychological medicine, 51(9), 1570-1580. https://doi.org/10.1017/S0033291720000409
Fagerlund, Birgitte, et al. "Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years." Psychological medicine vol. 51,9 (2021): 1570-1580. doi: https://doi.org/10.1017/S0033291720000409
Fagerlund B, Pantelis C, Jepsen JRM, Raghava JM, Rostrup E, Thomas MB, Nielsen MØ, Bojesen K, Jensen KG, Stentebjerg-Decara M, Klauber DG, Rudå D, Ebdrup BH, Jessen K, Sigvard A, Tangmose K, Jeppesen P, Correll CU, Fink-Jensen A, Pagsberg AK, Glenthøj BY. Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years. Psychol Med. 2021 Jul;51(9):1570-1580. doi: 10.1017/S0033291720000409. Epub 2020 Mar 11. PMID: 32156323.
Copy Download .nbib Format: NLM
CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.

Journal of clinical psychopharmacology

Rudå D, Jensen KG, Decara MS, Klauber DG, Fagerlund B, Møllegaard JR, Linnet K, Werge T, Correll CU, Fink-Jensen A, Jürgens G, Pagsberg AK.
PMID: 34735099
J Clin Psychopharmacol. 2021 Nov-Dec 01;41(6):667-672. doi: 10.1097/JCP.0000000000001490.

PURPOSE/BACKGROUND: The aim of this study was to examine the association between genetically predicted CYP2D6 phenotypes and extrapyramidal symptoms (EPSs).METHODS/PROCEDURES: Data from the Tolerability and Efficacy of Antipsychotics trial of adolescents with first-episode psychosis randomized to aripiprazole versus quetiapine...

Cite
Rudå D, Jensen KG, Decara MS, et al. CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis. J Clin Psychopharmacol. 2021;41(6):667-672doi: 10.1097/JCP.0000000000001490.
Rudå, D., Jensen, K. G., Decara, M. S., Klauber, D. G., Fagerlund, B., Møllegaard, J. R., Linnet, K., Werge, T., Correll, C. U., Fink-Jensen, A., Jürgens, G., & Pagsberg, A. K. (2021). CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis. Journal of clinical psychopharmacology, 41(6), 667-672. https://doi.org/10.1097/JCP.0000000000001490
Rudå, Ditte, et al. "CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis." Journal of clinical psychopharmacology vol. 41,6 (2021): 667-672. doi: https://doi.org/10.1097/JCP.0000000000001490
Rudå D, Jensen KG, Decara MS, Klauber DG, Fagerlund B, Møllegaard JR, Linnet K, Werge T, Correll CU, Fink-Jensen A, Jürgens G, Pagsberg AK. CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis. J Clin Psychopharmacol. 2021 Nov-Dec 01;41(6):667-672. doi: 10.1097/JCP.0000000000001490. PMID: 34735099.
Copy Download .nbib Format: NLM
Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering.

Scandinavian journal of public health

Fagerlund P, Salmela J, Pietiläinen O, Salonsalmi A, Rahkonen O, Lallukka T.
PMID: 34965800
Scand J Public Health. 2021 Dec 29;14034948211062314. doi: 10.1177/14034948211062314. Epub 2021 Dec 29.

BACKGROUND: Pain is known to be socioeconomically patterned and associated with disability. However, knowledge is scarce concerning life-course socioeconomic circumstances and pain among young adults. Our aim was to examine the associations of childhood and current socioeconomic circumstances with...

Cite
Fagerlund P, Salmela J, Pietiläinen O, et al. Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scand J Public Health. 2021;14034948211062314doi: 10.1177/14034948211062314.
Fagerlund, P., Salmela, J., Pietiläinen, O., Salonsalmi, A., Rahkonen, O., & Lallukka, T. (2021). Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scandinavian journal of public health, 14034948211062314. https://doi.org/10.1177/14034948211062314
Fagerlund, Pi, et al. "Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering." Scandinavian journal of public health vol. (2021): 14034948211062314. doi: https://doi.org/10.1177/14034948211062314
Fagerlund P, Salmela J, Pietiläinen O, Salonsalmi A, Rahkonen O, Lallukka T. Life-course socioeconomic circumstances in acute, chronic and disabling pain among young employees: a double suffering. Scand J Public Health. 2021 Dec 29;14034948211062314. doi: 10.1177/14034948211062314. Epub 2021 Dec 29. PMID: 34965800.
Copy Download .nbib Format: NLM
Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis.

Schizophrenia research

Kristensen TD, Glenthøj LB, Ragahava JM, Syeda W, Mandl RCW, Wenneberg C, Krakauer K, Fagerlund B, Pantelis C, Glenthøj BY, Nordentoft M, Ebdrup BH.
PMID: 34543833
Schizophr Res. 2021 Nov;237:192-201. doi: 10.1016/j.schres.2021.09.014. Epub 2021 Sep 17.

AIM: Growing evidence suggests that subtle white matter (WM) alterations are associated with psychopathology in individuals at ultra-high risk for psychosis (UHR). However, the longitudinal relationship between symptom progression and WM changes over time remains under-explored. Here, we examine...

Cite
Kristensen TD, Glenthøj LB, Ragahava JM, et al. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis. Schizophr Res. 2021;237:192-201doi: 10.1016/j.schres.2021.09.014.
Kristensen, T. D., Glenthøj, L. B., Ragahava, J. M., Syeda, W., Mandl, R. C. W., Wenneberg, C., Krakauer, K., Fagerlund, B., Pantelis, C., Glenthøj, B. Y., Nordentoft, M., & Ebdrup, B. H. (2021). Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis. Schizophrenia research, 237192-201. https://doi.org/10.1016/j.schres.2021.09.014
Kristensen, Tina D, et al. "Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis." Schizophrenia research vol. 237 (2021): 192-201. doi: https://doi.org/10.1016/j.schres.2021.09.014
Kristensen TD, Glenthøj LB, Ragahava JM, Syeda W, Mandl RCW, Wenneberg C, Krakauer K, Fagerlund B, Pantelis C, Glenthøj BY, Nordentoft M, Ebdrup BH. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis. Schizophr Res. 2021 Nov;237:192-201. doi: 10.1016/j.schres.2021.09.014. Epub 2021 Sep 17. PMID: 34543833.
Copy Download .nbib Format: NLM
Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men.

Frontiers in aging neuroscience

Rask L, Bendix L, Harbo M, Fagerlund B, Mortensen EL, Lauritzen MJ, Osler M.
PMID: 28018213
Front Aging Neurosci. 2016 Dec 09;8:300. doi: 10.3389/fnagi.2016.00300. eCollection 2016.

No abstract available.

Cite
Rask L, Bendix L, Harbo M, et al. Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men. Front Aging Neurosci. 2016;8:300doi: 10.3389/fnagi.2016.00300.
Rask, L., Bendix, L., Harbo, M., Fagerlund, B., Mortensen, E. L., Lauritzen, M. J., & Osler, M. (2016). Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men. Frontiers in aging neuroscience, 8300. https://doi.org/10.3389/fnagi.2016.00300
Rask, Lene, et al. "Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men." Frontiers in aging neuroscience vol. 8 (2016): 300. doi: https://doi.org/10.3389/fnagi.2016.00300
Rask L, Bendix L, Harbo M, Fagerlund B, Mortensen EL, Lauritzen MJ, Osler M. Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men. Front Aging Neurosci. 2016 Dec 09;8:300. doi: 10.3389/fnagi.2016.00300. eCollection 2016. PMID: 28018213; PMCID: PMC5145851.
Copy Download .nbib Format: NLM
WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information.

Therapeutic innovation & regulatory science

Lagerlund O, Strese S, Fladvad M, Lindquist M.
PMID: 32078733
Ther Innov Regul Sci. 2020 Sep;54(5):1116-1122. doi: 10.1007/s43441-020-00130-6. Epub 2020 Feb 20.

The WHODrug medicinal information dictionary is a worldwide source of global medicinal information with the aim to facilitate the coding of medications in clinical trials as well as identification of medication-related problems when monitoring patient safety, thereby supporting the...

Cite
Lagerlund O, Strese S, Fladvad M, et al. WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci. 2020;54(5):1116-1122doi: 10.1007/s43441-020-00130-6.
Lagerlund, O., Strese, S., Fladvad, M., & Lindquist, M. (2020). WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Therapeutic innovation & regulatory science, 54(5), 1116-1122. https://doi.org/10.1007/s43441-020-00130-6
Lagerlund, Olof, et al. "WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information." Therapeutic innovation & regulatory science vol. 54,5 (2020): 1116-1122. doi: https://doi.org/10.1007/s43441-020-00130-6
Lagerlund O, Strese S, Fladvad M, Lindquist M. WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information. Ther Innov Regul Sci. 2020 Sep;54(5):1116-1122. doi: 10.1007/s43441-020-00130-6. Epub 2020 Feb 20. PMID: 32078733; PMCID: PMC7458889.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries